Merck Vioxx Litigation Update
This article was originally published in The Pink Sheet Daily
Executive Summary
Merck will face six Vioxx (rofecoxib) liability trials in the next six months, including the second case to reach trial, scheduled to get underway Sept. 12 in Atlantic City, and the first federal case to reach trial, slated for Nov. 28